CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


momentasone furate nasal sprayWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)


Name (Synonyms) Correlation

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D000857 Olfaction Disorders NIH 0.27

Correlated HPO Terms (1)


Name (Synonyms) Correlation
HP:0000458 Anosmia HPO 0.27

There is one clinical trial.

Clinical Trials


1 Role of Corticosteroid Nasal Spray in Recovery of Smell Sensation in COVID-19 Patients

The aim of this study is to evaluate the role of the topical corticosteroids nasal spray (momentasonefuratenasal spray) in improving anosmia in patients recovered from COVID-19 infection.

NCT04484493 Covid19 Anosmia Drug: momentasone furate nasal spray
MeSH:Olfaction Disorders
HPO:Anosmia

Primary Outcomes

Description: The patient will report the degree of anosmia subjectively with score on a scale from 0 to 10 (0 means total loss of smell and 10 refers to completely normal smell sensation).

Measure: improvement of olfaction

Time: 3 weeks


Related HPO nodes (Using clinical trials)